Recent Updates
Recently added Catalysts
TLX Negative Sentiment Score: 20/100

Telix Pharmaceuticals Limited Investigated by the Portnoy Law Firm

Thursday, October 23, 2025 2 min read
Key Takeaway: Telix Pharmaceuticals Limited is facing an investigation by the Portnoy Law Firm over potential securities fraud. This comes after the company received a subpoena from the U.S. Securities and Exchange Commission regarding its disclosures related to prostate cancer therapeutic candidates. Following this news, Telix's stock price dropped significantly, reflecting investor concerns. The firm may file a class action on behalf of affected investors to recoup losses.

Market Sentiment Analysis

CONCERNS & RISKS

  • Investigation initiated into possible securities fraud involving Telix.
  • Company's stock price fell significantly after a subpoena from the SEC.
  • Potential class action lawsuit may indicate serious concerns regarding corporate governance.

Full Press Release Details

LOS ANGELES, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Telix Pharmaceuticals Limited, ("Telex" or the "Company") (NASDAQ: TLX) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/Telix-Pharmaceuticals-Limited. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On July 22, 2025, Telix disclosed receipt of a subpoena from the U.S. Securities and Exchange Commission, "seeking various documents and information primarily relating to the Company's disclosures regarding the development of the Company's prostate cancer therapeutic candidates." On this news, Telix's American Depositary Receipt ("ADR") price fell $1.70 per ADR, or 10.44%, to close at $14.58 per ADR on July 23, 2025.
The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
lesley@portnoylaw.com
Attorney Advertising

Tags

Frequently Asked Questions

What is the Portnoy Law Firm investigating?

The firm is investigating potential securities fraud involving Telix Pharmaceuticals.

How can investors contact the Portnoy Law Firm?

Investors can contact attorney Lesley F. Portnoy at 844-767-8529 or lesley@portnoylaw.com.

What triggered the investigation into Telix Pharmaceuticals?

The investigation was triggered by Telix receiving a subpoena from the SEC regarding disclosures.

What impact did the SEC subpoena have on Telix's stock?

Following the SEC subpoena, Telix’s ADR price dropped by $1.70, or 10.44%.

What services does the Portnoy Law Firm offer to investors?

The firm offers complimentary case evaluations and options for pursuing investor claims.

Tags: TLX Viatris Investor Conferences Healthcare Telix Pharmaceuticals securities fraud Portnoy Law Firm class action
Last updated: Oct 23, 2025